Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsAustin Gurney, Timothy Hoey, Fumiko Axelrod et al.|Proceedings of the National Academy of Sciences|2012Cited by 630
WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell deathMarcus Fischer, Timothy Hoey, Belinda Cancilla et al.|Science Advances|2017Cited by 156
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer TypesCécile Chartier, Austin Gurney, Janak Raval et al.|Cancer Research|2016Cited by 115
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Zoran Ranković, Lauren G. Mascibroda et al.|Nature Communications|2024Cited by 50
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitorsMladen Koravović, Vladimir Savić, Huarui Cui et al.|European Journal of Medicinal Chemistry|2023Cited by 9